Home › FDA Approval Pumps New Life Into Edwards Stock
 

Keywords :   


FDA Approval Pumps New Life Into Edwards Stock

2015-06-27 09:00:47| Biotech - Topix.net

With FDA approval for its new Sapien 3 artificial heart valve, Edwards Lifesciences is nearing a new buy point in a first-stage base. The maker of products to treat advanced cardiovascular disorders may also get a boost from the positive impact the Supreme Court's ObamaCare decision is having on medical and health care stocks.

Tags: life stock approval edwards

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.06Jotun Launches CX-Rated Anticorrosive Powder Coating
28.06RPM to Announce Fiscal 2024 4Q, Year-End Results
28.06Evonik Commissions New Plant for AEROSIL Silicas
28.06Martin Automatic celebrates successful return of drupa
28.06Pubco turns to HP for luxury packaging
28.06More flights cancelled as Aer Lingus dispute continues
28.06Rohit Aggarwal Joins Lenzing\'s Management Board and Named Designated CEO
28.06Fujitsu expert: I didn't think Horizon was a monster
More »